在早产婴儿的血清咖啡因度:一个回顾性研究
Masashiro Sugino1, Toru Kuboi2, Yuta Noguchi3
1Division of Neonatology, NHO Shikoku Medical Center for Children and Adults, 2-1-1 Senyu Cho, Zentsuji City, Kagawa, 765-8507, Japan. rmasashirod@yahoo.co.jp.
Scientific reports
|June 26, 2023
概括
通常不需要对早产婴儿的咖啡因进行治疗药物监测. 然而,每天8mg/kg或更高的剂量可能导致有毒咖啡因水平,需要进一步研究神经效应.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在早产性呼吸暂停中对咖啡因的治疗药物监测通常被认为是不必要的,因为血清度通常很低.
- 尽管如此,一些早产婴儿经历过咖啡因毒性.
研究的目的:
- 评估咖啡因维持剂量与早产婴儿血清度之间的关系.
- 为了确定与潜在毒性血清咖啡因水平相关的特定维持剂量.
主要方法:
- 一项涉及24名早产婴儿的回顾性观察性研究,这些婴儿因早产性呼吸暂停而接受咖啡因酸盐治疗.
- 对272个血清样本进行分析,以将咖啡因剂量与血清度相关联.
主要成果:
- 在咖啡因剂量和血清咖啡因度 (r=0.72,p<0.05) 之间观察到显著的正相关性.
- 大约15%的接受8毫克/公斤/天或更高剂量的婴儿的血清咖啡因度超过了建议的毒性水平.
结论:
- 8 mg/kg/day或更高的咖啡因剂量增加了早产婴儿达到建议的毒性血清咖啡因水平的风险.
- 这些高度咖啡因对神经系统的影响需要进一步研究,包括长期的神经发育随访.
相关概念视频
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...